A ""stop the rot"" ann today to firstly keep up their Governance...

A ""stop the rot"" ann today to firstly keep up their Governance by updating the GMP with-in timelines first given and secondly to stop the sell off..

Tax time has been and gone so no more ""loss"" selling for Tax reasons.

The most i take out of this is " this delay will directly impact on the commencement of clinical development activities for PAT-DX1"

. The Company believes the specification testing will be completed in the next 4 weeks and will advise if there are any further amendments or developments in relation to this revised timeline.

For many, the timeline to go to clinic this year was touch and go, with this delay it almost certainly looks like it will be early next year..

At least for now the rot has stopped, could this have been achieved without this delay of an Ann with the financial year behind us? probably, but most would agree that updating with a renewed timeline for GMP results is welcome..

The volume for the sell off was not heavy, but heavy enough to lift the eyebrows again if this is a failed GMP, time will tell.